Recent developments in hormonal assay have yielded biological methods of clinical importance in the early diagnosis and prognosis of teratoma testis. From reports of large series of patients suffering from this condition it would seem that the response of these tumors to radiation is accompanied by variations in the quantities of hormone excreted in the urine with such regularity as to render the quantitative determination of prolan A in the urine an accurate guide in prognosis and treatment.
The purpose of this communication is to present the results of studies dealing with the presence of prolan A (the sex hormone of the anterior hypophysis) in the urine of patients suffering from teratoma testis, arid to discuss the diagnostic and therapeutic significance of these observations. Zondek, in 1930, was the first to report an increased excretion of prolan A in the urine of patients suffering from teratoma testis. Heidrich, Fels and Mathias next (1930) applied this test to a case of chorionepithelioma of the testis, in which examination of the urine just before death revealed 50,000 mouse units per liter (prolan A and B). In 1931 Ferguson, Downes, Ellis, and Nicholson issued a preliminary note upon the use of the Aschheim-Zondek test in the diagnosis of teratoma testis, first reporting the observation that irradiation of the tumor is followed by the disappearance of prolan A from the urine and noting the absence of the hormone in benign lesions of the testis. I n 1932
Zondek examined hydrocele fluid, urine, and tumor tissue from 14 patients suffering from teratoma testis. Ferguson, who has reviewed the literature upon the subject up to June 1933, cites nine publications reporting single cases in which prolan ,A determinations were made upon urine of patients before or after operation for teratoma testis. It remained for him to place the study on a comprehensive basis, with a report of 117 consecutive cases of teratoma testis in which the behavior of prolan A was studied by meaiis of an extensive series of biological tests.
Ferguson's conclusions were as follows: 1. The patient with teratoma testis will excrete from 50 to 50,000 mouse units of prolan A per liter of urine, depending upon the embryonal character of the tumor, the extent of the disease, and the status as regards treatment. I n a subsequent report Ferguson presents an additional case of teratoma testis and emphasizes the relationship between the embryonal character of the tumor and the quantity of prolan A excretion in the urine.
Lindsay, in 1933, reported upon the value of the Aschheim-Zondek test in teratoma testis. I n one patient in whom the test was negative the testicular lesion proved to be a hydrocele. In 1934 Stelle reported fifteen cases of teratoma testis studied biologically and microscopically. Ewing 's histological classification was adopted. Quantitative estimates were not made, but the results confirm the value of the test. I n 1934 Fluhmann and Hoffman reported the presence of 2500 rat units of prolan A in one liter of urine of a patient suffering from teratoma testis and noted a rapid increase in the weight of the ovaries in the experimental animals. They concluded that the gonad-stimulating hormone in the urine of a patient with teratoma testis has the same characteristics as the substance occurring in the urine of pregnant women.
TECHNIC OF EXTRACTION
Most procedures for the extraction of gonadotropic materials from the urine of pregnancy employ chemical agents which may cause a noticeable loss of activity, as cited by Wiesner and Marshall (1931) , and by Katzman and Doisy (1932) . Other chemicals, such as tungstic acid, phosphotungstic acid, tannic acid, and colloidal iron, also present disadvantages, chiefly the difficulty of separating them from the final product. We have employed two methods in the concentration of prolan A. One is a modification of Zondek's (1930) technic and the other is a benzoic acid floc method similar to that recently described by Katzman and Doisy.
Method 1: Urine specimens are obtained fresh or through a mailing system, mailed specimens being preserved by the addition of one drop of tricresol for each 200 C.C. of urine. On receipt of the specimen, it is acidified to pH 4.5 to 5.0 by the addition of acetic acid. The specimen is then placed in a chilling chamber and later filtered while cold. Five volumes of chilled 95 per cent ethyl alcohol are then added. The suspension is strongly agitated and kept at 10" C. over night. The precipitate is obtained by centrifuging and the supernatant fluid is discarded. The precipitate is next washed with either ether or acetone, equal in volume to the original sample used, which is usually about 50
The washed precipitate is allowed to dry a t room temperature, after which it is strongly agitated with water to yield a concentration five t,o ten times that of the original urine volume. The water-insoluble residue is discarded and the solution containing the active principle is used for testing.
Method 2: The benzoic acid floc method of concentration as used by us is as follows: To 100 C.C. of the acidified, chilled, and clarified urine specimen are added 10 c.c. of chilled acetone previously saturated with benzoic acid. Constant, violent agitation of the urine specimen is employed while the acetone-benzoic acid solution is added from a dropping funnel drop by drop. The precipitate is obtained by use of a suction filtration apparatus, aft,er which it is washed with a chilled, saturated aqueous solution of benzoic acid. The dry precipitate is then placed in 20 C.C. of chilled acetone. The insoluble residue from this solution is obtained by centrifuging. The residue is then washed with two 10 C.C.
portions of chilled acetone, after which it is allowed to dry at room temperature. For purposes of assay the residue is taken up in water to give a five-fold to one-hundred-fold concentration. All water-insoluble material is discarded or retained for subsequent reference. Occasionally, the residue is extracted with 0.002 normal sodium hydroxide, but we have found that either acids or alkalies of 0.02 normal or over destroy 25 per cent or more of the activity when in contact for one hour or longer.
QUANTITATIVE DETERMINATION OF PROLAN A
Mice are used as the experimental animals in our biological assays. These animals are virgin, immature females weighing not over 8 grams and are not more than four weeks old a t the termination of t,he test. 
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The positive microscopic changes that are produced in the tubes and ovaries of mice receiving prolan A injections have been previously described, and are as follows : ( a ) hyperemia of the graafian follicles with development of a distinct cumulus oophorus and canalization and hyperemia of the tubes; ( b ) formation of corpora hemorrhagica, occupying the normal site of the ova; ( c ) the formation of corpora lutea. The first two of these changes ( a and b ) are attributed to prolan A and the third (c) is attributed to the presence of prolan B. I n all determinations in which positive tests were obtained the twenty-four-hour output of urine was determined. Any marked variations from the normal volume output were noted in order to correct for dilution and concentration, which, if not considered, yield false variations due not to changes in total hormone output but to differences in urinary volume.
RESULTS
This report deals with 66 patients suffering from teratoma testis, upon whom more than 200 quantitative determinations of prolan A were made. The results of these observations are recorded in Table 11 . It would appear from these data that some relation exists between the quantity of hormone excreted in the urine and the final result. Actually, other factors, such as the extent of the disease, the degree of malignancy, and the treatment administered, each playing its r81e, influence the clinical course and mask any relationship that may exist between the quantity of hormone excreted and the ultimate outcome. 
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Prolaa A Determilzatiolzs ilz Control Series: Zondek (1932) has reported 40 instances in normal men and men with non-neoplastic diseases of the prostate in which the prolan A excretion in the urine was normal. Ferguson reports on 200 normal men and men with benign lesions of the testis whose urines yielded negative tests for prolan A, and regards such findings of great aid in differential diagnosis. Further negative controls have been reported by Kegel, Branch (cited by Ferguson), and Ferro (1932). The writers have examined 13 patients with benign lesions of the testis with negative results and are able to confirm the belief that normal men and men suffering from benign testicular lesions excrete less than 50 mouse units per liter of urine. Table I11 
